Lambert-Eaton myasthenic syndrome in children

Journal of Child Neurology

Volumn 17, Issue 1, 2002, Pages 74-76

  Tsao, Chang Yong ^a   Mendell, Jerry R ^a   Friemer, Miriam L ^a   Kissel, John T ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; ANTISTREPTOLYSIN; CALCIUM; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CHOLINERGIC RECEPTOR ANTIBODY; CREATINE KINASE; CYCLOSPORIN; DYSTROPHIN; IMMUNOGLOBULIN G; MEPREDNISONE; PREDNISONE; PYRIDOSTIGMINE; RHEUMATOID FACTOR;

ARTICLE; AUTONOMIC DYSFUNCTION; CASE REPORT; CHILD; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; EATON LAMBERT SYNDROME; ELECTROMYOGRAM; FEMALE; HUMAN; HYPOREFLEXIA; LUNG SMALL CELL CANCER; MALE; MUSCLE WEAKNESS; NERVE STIMULATION; NEUROMUSCULAR TRANSMISSION; PLASMAPHERESIS; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL;

AUTOANTIBODIES; CALCIUM CHANNELS, P-TYPE; CALCIUM CHANNELS, Q-TYPE; CHILD; CYCLOSPORINE; ELECTRIC STIMULATION; FEMALE; HUMANS; LAMBERT-EATON MYASTHENIC SYNDROME; MALE; MEDIAN NERVE; NEUROLOGIC EXAMINATION; SYNAPTIC TRANSMISSION; ULNAR NERVE;

EID: 0036120281     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380201700123     Document Type: Article

References (18)

1. Defect of neuromuscular conduction associated with malignant neoplasms
2. Myasthenic syndromes
3. The Lambert-Eaton myasthenic syndrome. A review of 50 cases
4. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes
5. The Eaton-Lambert syndrome and autoimmune disorders
6. Autoimmunity in the Lambert-Eaton myasthenic syndrome
7. Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome
8. A myasthenic syndrome in childhood leukemia
9. Lambert-Eaton myasthenic syndrome (LEMS) in association with lymphoproliferative disorders
10. Eaton-Lambert syndrome in a 9-year-old girl
11. Unusual myasthenic state in a teen-age boy
12. Diagnostic difficulties encountered in the myasthenic syndrome sometimes associated with carcinoma
13. Congenital Lambert-Eaton myasthenic syndrome
14. Treatment with oral 4-aminopyridine in disorders of neuromuscular transmission
15. 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome
16. Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome
17. Current treatment of neuromuscular diseases
18. Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome